• Please log in or register to access this feature.

Clinical immunology

You have full text access to this OnlineOpen article

IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL

  1. Peter Dubsky1,2,
  2. Hiroaki Saito1,
  3. Marylene Leogier1,
  4. Carole Dantin1,
  5. John E. Connolly1,
  6. Jacques Banchereau1,
  7. A. Karolina Palucka1,*

Article first published online: 9 MAY 2007

DOI: 10.1002/eji.200636329

Issue

European Journal of Immunology

European Journal of Immunology

Volume 37, Issue 6, pages 1678–1690, June 2007

Additional Information

How to Cite

Dubsky, P., Saito, H., Leogier, M., Dantin, C., Connolly, John E., Banchereau, J. and Palucka, A. Karolina. (2007), IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Eur. J. Immunol., 37: 1678–1690. doi: 10.1002/eji.200636329

Author Information

  1. 1

    Baylor Institute for Immunology Research, Baylor NIAID Cooperative Center for Translational Research on Human Immunology and Biodefense, Dallas, USA

  2. 2

    Medical University of Vienna, Department of Surgery, Vienna, Austria

*BIIR, 3434 Live Oak, Dallas, 75204 TX, USA, Fax: +1-214-8204813

Publication History

  1. Issue published online: 24 MAY 2007
  2. Article first published online: 9 MAY 2007
  3. Manuscript Accepted: 4 APR 2007
  4. Manuscript Revised: 24 FEB 2007
  5. Manuscript Received: 30 MAY 2006

Funded by

  • Baylor Health Care Systems Foundation
  • NIH
  • FWF Austria

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (664K)
  • 1
    Steinman, R. M. and Dhodapkar, M., Active immunization against cancer with dendritic cells: The near future. Int. J. Cancer 2001. 94: 459–473.
    Direct Link:
  • 2
    Davis, I. D., Jefford, M., Parente, P. and Cebon, J., Rational approaches to human cancer immunotherapy. J. Leukoc. Biol. 2003. 73: 3–29.
  • 3
    Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767–811.
  • 4
    Shortman, K. and Liu, Y. J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151–161.
  • 5
    Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G. et al., Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994. 180: 83–93.
  • 6
    Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109–1118.
  • 7
    Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D. and Glaspy, J. A., Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukoc. Biol. 1998. 64: 358–367.
  • 8
    Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J. and Cebon, J., Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 1998. 161: 1947–1953.
  • 9
    Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T. and Belardelli, F., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000. 191: 1777–1788.
  • 10
    Chomarat, P., Dantin, C., Bennett, L., Banchereau, J. and Palucka, A. K., TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 2003. 171: 2262–2269.
  • 11
    Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Durand, I., Cella, M., Lanzavecchia, A. and Banchereau, J., CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 1997. 90: 1458–1470.
  • 12
    Banchereau, J., Palucka, A. K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S. et al., Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 2001. 61: 6451–6458.
  • 13
    Paczesny, S., Banchereau, J., Wittkowski, K. M., Saracino, G., Fay, J. and Palucka, A. K., Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J. Exp. Med. 2004. 199: 1503–1511.
  • 14
    Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., Davoust, J., Bridges, G. et al., Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 2001. 194: 1013–1020.
  • 15
    Dubois, S., Mariner, J., Waldmann, T. A. and Tagaya, Y., IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 2002. 17: 537–547.
  • 16
    Musso, T., Calosso, L., Zucca, M., Millesimo, M., Ravarino, D., Giovarelli, M., Malavasi, F. et al., Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 1999. 93: 3531–3539.
  • 17
    Neely, G. G., Epelman, S., Ma, L. L., Colarusso, P., Howlett, C. J., Amankwah, E. K., McIntyre, A. C. et al., Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. J. Immunol. 2004. 172: 4225–4234.
  • 18
    Alves, N. L., Hooibrink, B., Arosa, F. A. and van Lier, R. A., IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 2003. 102: 2541–2546.
  • 19
    Seder, R. A., Grabstein, K. H., Berzofsky, J. A. and McDyer, J. F., Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 1995. 182: 1067–1077.
  • 20
    Castelli, J., Thomas, E. K., Gilliet, M., Liu, Y. J. and Levy, J. A., Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: The role of IL-15. Blood 2004. 103: 2699–2704.
  • 21
    Ferlazzo, G., Pack, M., Thomas, D., Paludan, C., Schmid, D., Strowig, T., Bougras, G. et al., Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 2004. 101: 16606–16611.
  • 22
    Takata, H., Tomiyama, H., Fujiwara, M., Kobayashi, N. and Takiguchi, M., Cutting Edge: Expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J. Immunol. 2004. 173: 2231–2235.
  • 23
    Hess, C., Means, T. K., Autissier, P., Woodberry, T., Altfeld, M., Addo, M. M., Frahm, N. et al., IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 2004. 104: 3463–3471.
  • 24
    Pardoll, D., Does the immune system see tumors as foreign or self? Annu. Rev. Immunol. 2003. 21: 807–839.
  • 25
    Medema, J. P., de Jong, J., Peltenburg, L. T., Verdegaal, E. M., Gorter, A., Bres, S. A., Franken, K. L. et al., Blockade of the Granzyme B/Perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA 2001. 98: 11515–11520.
  • 26
    Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L. et al., Inhibition of death receptor signals by cellular FLIP. Nature 1997. 388: 190–195.
  • 27
    Bennett, F., Luxenberg, D., Ling, V., Wang, I. M., Marquette, K., Lowe, D., Khan, N. et al., Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 2003. 170: 711–718.
  • 28
    McMahon, C. W. and Raulet, D. H., Expression and function of NK cell receptors in CD8+ T cells. Curr. Opin. Immunol. 2001. 13: 465–470.
  • 29
    Oh, S., Berzofsky, J. A., Burke, D. S., Waldmann, T. A. and Perera, L. P., Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc. Natl. Acad. Sci. USA 2003. 100: 3392–3397.
  • 30
    Brandt, K., Bulfone-Paus, S., Foster, D. C. and Ruckert, R., Interleukin-21 inhibits dendritic cell activation and maturation. Blood 2003. 102: 4090–4098.
  • 31
    Pulendran, B., Dillon, S., Joseph, C., Curiel, T., Banchereau, J. and Mohamadzadeh, M., Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo. Eur. J. Immunol. 2004. 34: 66–73.
    Direct Link:
  • 32
    Feau, S., Facchinetti, V., Granucci, F., Citterio, S., Jarrossay, D., Seresini, S., Protti, M. P. et al., Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 2005. 105: 697–702.
View Full Article (HTML) Get PDF (664K)